Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications
The American Federation for Medical Research maintains commitment to decades of support of vaccine and vaccination research to improve public health.
Journal: Journal of investigative medicine : the official publication of the American Federation for Clinical Research
Published: March 01, 2025
Families with multiple individuals with acute leukemia in their pedigrees.
Journal: Journal of investigative medicine : the official publication of the American Federation for Clinical Research
Published: June 13, 2024
Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 26, 2024
Families with non-Hodgkin lymphoma and plasma cell dyscrasias in their pedigrees.
Journal: Journal of investigative medicine : the official publication of the American Federation for Clinical Research
Published: October 21, 2023
Results From a Randomized Phase II Trial of Sunitinib and Gemcitabine or Sunitinib in Advanced Renal Cell Carcinoma with Sarcomatoid Features: ECOG-ACRIN E1808.
Journal: Clinical genitourinary cancer
Published: June 07, 2023
Adjuvant therapy in patients with sarcomatoid renal cell carcinoma: post hoc analysis from Eastern Cooperative Oncology Group-American College of Radiology Imaging Network (ECOG-ACRIN) E2805.
Journal: BJU international
Published: September 04, 2021
Gender effects in cancer treatment and outcome.
Journal: British journal of haematology
Published: June 19, 2021
Long-term progression-free survival of patients with metastatic melanoma or renal cell carcinoma following high-dose interleukin-2.
Journal: Journal of investigative medicine : the official publication of the American Federation for Clinical Research
Published: February 05, 2021
Plasma KIM-1 Is Associated with Recurrence Risk after Nephrectomy for Localized Renal Cell Carcinoma: A Trial of the ECOG-ACRIN Research Group (E2805).
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 05, 2021
Predicting Disease Recurrence, Early Progression, and Overall Survival Following Surgical Resection for High-risk Localized and Locally Advanced Renal Cell Carcinoma.
Journal: European urology
Published: October 12, 2020
On the Shoulders of Giants: The Evolution of Renal Cell Carcinoma Treatment-Cytokines, Targeted Therapy, and Immunotherapy.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: April 04, 2020
Last Updated: 09/26/2026